Use of nutrition to prevent stress-induced immunosuppression in the pediatric intensive care unit: A clinical trials minefield

Journal of Parenteral and Enteral Nutrition

Volumn 33, Issue 4, 2009, Pages 440-441

  Neu, Josef ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENEPROTEIN; GLUTAMINE; METOCLOPRAMIDE; PLACEBO; PROTEIN; SELENIUM; UNCLASSIFIED DRUG; ZINC;

CAUSE OF DEATH; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DIET SUPPLEMENTATION; EDITORIAL; GROUPS BY AGE; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; LYMPHOCYTOPENIA; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; SEPSIS; STRESS; STRESS INDUCED IMMUNOSUPPRESSION;

CRITICAL ILLNESS; CROSS INFECTION; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; GLUTAMINE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS; STRESS, PHYSIOLOGICAL;

EID: 67649212128     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607108328521     Document Type: Editorial

References (2)

1. Carcillo J., Holubkov R., Dean JM, et al. and the Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network. Rationale and design of the pediatric Critical Illness Stress-induced Immune Suppression (CRISIS) prevention trial. JPEN J Parenter Enteral Nutr. 2009 ; 33 (x). xxx - xxx.
2. Poindexter BB, Ehrenkranz RA, Stoll BM, et al. Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants. Pediatrics 2004 ; 113: 1209-1215. (Pubitemid 38580682)